September 24, 2008
454 Life Sciences, a Roche company, and Integrated DNA Technologies, Inc., Coralville, USA announced today they have entered into an exclusive co-promotional agreement wherein IDT will design, synthesize, and purify the fusion primers required for certain 454 Sequencing applications. These applications include ultra-deep amplicon sequencing for detection of low-frequency mutations in disease associated genes, and [...]
September 24, 2008
FROM INTERPHEX, BOOTH #215 -- Ahura Scientific, Inc., a leader in rugged, ultra-compact handheld instruments for chemical identification, today announced that it has launched TruScan(TM) 1.2 at INTERPHEX in Montreal, Canada. TruScan 1.2 enables companies to develop new libraries of materials, typically referred to as "methods," from any location and share them via network management [...]
September 24, 2008
Synamatix today announced its partnership with GeneWorks for the provision of sequencing and bioinformatics research support to key customers within Asia and Australia. The two companies will provide genome institutes in Asia with an extensive and comprehensive range of sequencing and bioinformatics solutions to support and enhance research. Kuala Lumpur (PRWEB) September 24, 2008 -- [...]
September 24, 2008
Madison, WI. (September 24, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, announces the availability of a new and improved version of its popular, interactive Web-based tool, updated to provide even more product and accessory solutions to UV-Visible customers. The intuitive Web selector guide, available at www.thermo.com/selectuv, allows current and prospective [...]
Emerson introduces multiparameter intelligent analyzer with three measurement inputs
September 24, 2008
New instrument offers expanded analytical inputs and multiple analog outputs to serve OEMs, systems integrators and analytical end users IRVINE, Calif., September 24, 2008 – To meet the need for multiple liquid measurements and lower costs per measurement loop required by industrial OEMs and other analytical customers, Emerson Process Management has announced the Rosemount Analytical [...]
New instrument can quickly examine multiple proteins in a single cancer sample
September 23, 2008
PHILADELPHIA -- Researchers have demonstrated a new instrument that makes it possible to detect and quantify multiple different clinically important proteins in a single tumor sample using conventional staining. Currently, pathologists usually need a separate tissue slice for each protein they want to examine, making it impossible to see how molecules interact within individual cells. [...]
LabVantage Awarded GSA Schedule Contract To Simplify LIMS Procurement by Federal Agencies
September 23, 2008
Bridgewater, NJ. September 23, 2008. LabVantage announced today that it has been awarded a five-year Information Technology (IT) Schedule 70 Contract with the United States (U.S.) General Services Administration (GSA) to sell its SAPPHIRE Laboratory Information Management Suite (LIMS) and related services to eligible U.S. federal agencies and their subordinate entities. The GSA Schedule leverages [...]
September 23, 2008
Acquisition of Center for Molecular Medicine Positions Sequenom for Commercial Launch of SEQureDx(TM) Test in First Half 2009 Daniel H. Farkas, Ph.D. to Join Sequenom Management Team SAN DIEGO--Sequenom (NASDAQ:SQNM - News) today announced that it entered into an agreement to acquire the Center for Molecular Medicine (CMM), a Clinical Laboratory Improvement Act (CLIA) certified [...]
U.S. Genomics Inc. Receives $4.5 Million Investment from BD
September 23, 2008
WOBURN, Mass., Sept. 23 -- U.S. Genomics today announced it has received a $4.5 million equity investment from BD (Becton, Dickinson and Company) and that the companies have entered into a strategic collaboration for development of a novel infectious disease diagnostic platform. The collaboration will focus on application of U.S. Genomics' DirectLinear Analysis(TM) technology (DLA) [...]
ForteBio, Inc. Closes $25 Million In Series C Financing
September 23, 2008
MENLO PARK, Calif., Sept. 23 -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of life science and pharmaceutical products, today announced the closing of $25 million in Series C financing, led by OrbiMed Advisors, a top global healthcare investment firm. MPM Capital also participated as a new investor in this [...]
